Structural basis for the inhibitor recognition of human Lyn kinase domain

Structural basis for the inhibitor recognition of human Lyn kinase domain Protein kinase inhibition of clinically important staurosporine analogues Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives Homology Modeling of Human Fyn Kinase Structure:  Discovery of Rosmarinic Acid as a New Fyn Kinase Inhibitor and in Silico Study of Its Possible Binding Modes Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies Structural influences of styryl-based inhibitors on epidermal growth factor receptor and p56lck tyrosine-specific protein kinases. Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases Crystal Structures of Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Isoquinolinesulfonyl Protein Kinase Inhibitors H7, H8, and H89 Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity Synthesis, structure–activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors